Scientific Committee
Prof. Varda Shalev, MD, MPA, Managing Partner, Team8 Health
Iris Grossman, PhD, Chief Therapeutics Officer, Eleven Therapeutics
Sandra Morgan, MBA, Board Director and Advisor, Healthcare, Medical Technology, and Pharmaceutical
Sharon Kaplinsky, Founder & CEO, Star Tree Ventures
Susan Finston, Senior Advisor, Princeton Pharma Capital Advisors
Anat Naschitz, CEO, 9xchange
Ofer Sharon, MD, CEO, OncoHost
Prof. Nir Friedman, PhD, The Hebrew University
Yair Benita, PhD, CTO, Aion Labs
Barry Greene, Chief Executive Officer, Sage Therapeutics
Nathalie Bloch, MD, MPA, Senior Advisor, Israel Innovation Authority
Tehila Ben Moshe, PhD, CEO, Biond Biologics
Yaron Daniely, PhD, Partner, aMoon
Dvir Cohen, CEO and President, Momentis Surgical
Prof. Anat Loewenstein, MD, Head of Ophthalmology Department, Tel Aviv Sourasky Medical Center, Ichilov
Dr. Barak Azmon, Director, Presby
Tammy Meiron, PhD, Chief Technology Officer, FreshStart FoodTech Incubator
Aviv Shoher, Managing Partner, IMed Capital
Shy Zyman, MBA, Partner, Cukierman & Co and Laurent Choppe, PhD, MBA, Managing Partner, Cukierman & Co. Life Sciences
Daphna Murvitz, LLB, Co-Founder and CEO, 8400 Health Network
Prof. Dror Harats, MD, Vice President research & Development, Sheba Tel-HaShomer Medical Center